In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help ...

The report by GlobalData, a data and analytics company, showed that anti-obesity medications are the industry trend that will ...

Its active ingredient is semaglutide, a glucagon-like peptide-1 (GLP-1 ... is available by prescription only and is used as a weekly injection to help with blood sugar management and help reduce ...

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Ozempic and Wegovy are two popular injectable medications for weight loss and diabetes. But what’s the difference?

Popular weight management drugs like Ozempic only come in injectable form ... companies are working to create a pill version of a glucagon-like peptide 1 (GLP-1) receptor agonist, which would ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

I nvesting.com -- The European market is facing shortages of Novo Nordisk's (NYSE:NVO) injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA), Ozempic, a critical medication for managing ...

Second, Amneal has received approval from the FDA for exenatide, which is the Company’s first generic injectable glucagon-like peptide-1 (GLP-1) agonist and reflects its innovation capabilities ...